Free Trial

Bolt Biotherapeutics (BOLT) News Today

Bolt Biotherapeutics logo
Stifel Nicolaus Remains a Hold on Bolt Biotherapeutics (BOLT)
Vivo Opportunity Fund Holdings, L.P.'s Net Worth
Bolt Biotherapeutics: First Patient Dosed In Clinical Trial Of BDC-3042
Get Bolt Biotherapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BOLT and its competitors with MarketBeat's FREE daily newsletter.

Trump won. Buy this coin now. (Ad)

Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.

This could be his favorite coin.

BOLT Media Mentions By Week

BOLT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BOLT
News Sentiment

0.00

0.56

Average
Basic Materials
News Sentiment

BOLT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BOLT Articles
This Week

0

0

BOLT Articles
Average Week

Get Bolt Biotherapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BOLT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (CNSX:BOLT) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners